248 related articles for article (PubMed ID: 12617274)
41. Fatigue in multiple sclerosis: relation to depression, physical impairment, personality and action control.
Penner IK; Bechtel N; Raselli C; Stöcklin M; Opwis K; Kappos L; Calabrese P
Mult Scler; 2007 Nov; 13(9):1161-7. PubMed ID: 17967844
[TBL] [Abstract][Full Text] [Related]
42. Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
Krause I; Kern S; Horntrich A; Ziemssen T
Mult Scler; 2013 Nov; 19(13):1792-9. PubMed ID: 23635910
[TBL] [Abstract][Full Text] [Related]
43. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
44. A cross-sectional study of alexithymia in patients with relapse remitting form of multiple sclerosis.
Stojanov J; Stojanov A
J Postgrad Med; 2020; 66(1):23-27. PubMed ID: 31929308
[TBL] [Abstract][Full Text] [Related]
45. Correlates of cognitive impairment and depressive mood disorder in multiple sclerosis.
Möller A; Wiedemann G; Rohde U; Backmund H; Sonntag A
Acta Psychiatr Scand; 1994 Feb; 89(2):117-21. PubMed ID: 8178661
[TBL] [Abstract][Full Text] [Related]
46. Biomedical Variables and Adaptation to Disease and Health-Related Quality of Life in Polish Patients with MS.
Dymecka J; Bidzan M
Int J Environ Res Public Health; 2018 Nov; 15(12):. PubMed ID: 30486508
[TBL] [Abstract][Full Text] [Related]
47. Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis.
Kiy G; Lehmann P; Hahn HK; Eling P; Kastrup A; Hildebrandt H
Mult Scler; 2011 Sep; 17(9):1088-97. PubMed ID: 21546523
[TBL] [Abstract][Full Text] [Related]
48. A longitudinal study on fatigue, depression, and their relation to neurocognition in multiple sclerosis.
Hildebrandt H; Eling P
J Clin Exp Neuropsychol; 2014; 36(4):410-7. PubMed ID: 24702275
[TBL] [Abstract][Full Text] [Related]
49. Altered cytokine responses to cognitive stress in multiple sclerosis patients with fatigue.
Heesen C; Koehler G; Gross R; Tessmer W; Schulz KH; Gold SM
Mult Scler; 2005 Feb; 11(1):51-7. PubMed ID: 15732267
[TBL] [Abstract][Full Text] [Related]
50. Anxiety and depressive symptoms in caregivers of multiple sclerosis patients: The role of information processing speed impairment.
Labiano-Fontcuberta A; Mitchell AJ; Moreno-García S; Benito-León J
J Neurol Sci; 2015 Feb; 349(1-2):220-5. PubMed ID: 25638658
[TBL] [Abstract][Full Text] [Related]
51. Fatigue, depression and disability accumulation in multiple sclerosis: a cross-sectional study.
Koch M; Mostert J; Heerings M; Uyttenboogaart M; De Keyser J
Eur J Neurol; 2009 Mar; 16(3):348-52. PubMed ID: 19490071
[TBL] [Abstract][Full Text] [Related]
52. Helplessness and loss as mediators between pain and depressive symptoms in fibromyalgia.
Palomino RA; Nicassio PM; Greenberg MA; Medina EP
Pain; 2007 May; 129(1-2):185-94. PubMed ID: 17335975
[TBL] [Abstract][Full Text] [Related]
53. [Impact of fatigue in multiple sclerosis: study of a population-based series in Valladolid].
Tola MA; Yugueros MI; Fernández-Buey N; Fernández-Herranz R
Rev Neurol; 1998 Jun; 26(154):930-3. PubMed ID: 9658463
[TBL] [Abstract][Full Text] [Related]
54. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).
Greim B; Benecke R; Zettl UK
J Neurol; 2007 May; 254 Suppl 2():II58-64. PubMed ID: 17503131
[TBL] [Abstract][Full Text] [Related]
55. [Fatigue in multiple sclerosis relapsing-remitting form].
Mendes MF; Tilbery HP; Balsimell S; Felipe E; Moreira MA; Barão-Cruz AM
Arq Neuropsiquiatr; 2000 Jun; 58(2B):471-5. PubMed ID: 10920409
[TBL] [Abstract][Full Text] [Related]
56. Longitudinal course of depression symptoms in multiple sclerosis.
Arnett PA; Randolph JJ
J Neurol Neurosurg Psychiatry; 2006 May; 77(5):606-10. PubMed ID: 16614019
[TBL] [Abstract][Full Text] [Related]
57. Relationships among depressive symptoms, benefit-finding, optimism, and positive affect in multiple sclerosis patients after psychotherapy for depression.
Hart SL; Vella L; Mohr DC
Health Psychol; 2008 Mar; 27(2):230-8. PubMed ID: 18377142
[TBL] [Abstract][Full Text] [Related]
58. Neuropsychiatric manifestations in multiple sclerosis: correlation of fatigue and depression with disease progression.
Kale N; Agaoglu J; Tanik O
Neurol Res; 2010 Mar; 32(2):221-3. PubMed ID: 19660239
[TBL] [Abstract][Full Text] [Related]
59. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
Silva AM; Santos E; Moreira I; Bettencourt A; Coutinho E; Gonçalves A; Pinto C; Montalban X; Cavaco S
Mult Scler; 2012 May; 18(5):616-21. PubMed ID: 22020420
[TBL] [Abstract][Full Text] [Related]
60. Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis.
Montel SR; Bungener C
Mult Scler; 2007 Apr; 13(3):393-401. PubMed ID: 17439909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
